Found: 6
Select item for more details and to access through your institution.
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41392-022-00878-3
- By:
- Publication type:
- Article
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00438-7
- By:
- Publication type:
- Article
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 4, p. 1, doi. 10.1002/jmv.28680
- By:
- Publication type:
- Article
SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 3, p. 1, doi. 10.1002/jmv.28561
- By:
- Publication type:
- Article
SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 11, p. 5174, doi. 10.1002/jmv.27965
- By:
- Publication type:
- Article
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 9, p. 5376, doi. 10.1002/jmv.27050
- By:
- Publication type:
- Article